Neurocognition as a moderator and mediator in adolescent substance misuse prevention

American Journal of Drug and Alcohol Abuse

Volumn 35, Issue 4, 2009, Pages 209-213

  Riggs, Nathaniel R ^a   Greenberg, Mark T ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Executive cognitive function; Intervention; Substance misuse

Indexed keywords

ADOLESCENT; ADOLESCENT HEALTH; ADULT; BRAIN DEVELOPMENT; COGNITION; DECISION MAKING; EMOTION; FRONTAL CORTEX; HUMAN; PREVENTIVE HEALTH SERVICE; PROPHYLAXIS; REVIEW; REWARD; SUBSTANCE ABUSE;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADOLESCENT DEVELOPMENT; BRAIN; COGNITION; HUMANS; MODELS, PSYCHOLOGICAL; NEUROPSYCHOLOGY; SUBSTANCE-RELATED DISORDERS;

EID: 70749089881     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.1080/00952990903005940     Document Type: Review

References (36)

1. Pentz MA, Dwyer JH, MacKinnon DP, Flay BR, Hansen WB, Wang EI, Johnson CA. A multicommunity trial for primary prevention of adolescent drug abuse. JAMA 1989; 261:3259-3266.
2. Sussman S, DentCW, StacyAW. Project TowardsNoDrugAbuse:Areview of the findings and future directions. Am J Health Behav 2002; 26:354-1265
3. Botvin GJ, Dusenbury L, Baker E, James-Ortiz S, Botvin EM, Kernet J. Smoking prevention among urban minority youth: assessing effects on outcome and mediating variables. Health Psychol 1992; 11:290-299.
4. MacKinnon DP, Johnson CA, Pentz MA, Dwyer JH, Hansen WB, Flay BR, Wang EYI. Mediating mechanisms in a school-based drug prevention program: First year effects of the Midwestern Prevention Project. Health Psychol 1993; 10:164-172.
5. Chambers RA, Taylor JR, Potenza MN. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiat 2003; 160:1041-1052.
6. Aggleton JP. The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction. New York, NY: Wiley-Liss, 1992.
7. Gogtay N, Giedd J,Rapoport JL. Brain development in healthy, hyperactive, and psychotic children. Arch Neurol 2002; 59:1244-1248.
8. Welsh MC, Pennington BF, Groisser DB. Anormative-developmental study of executive function: A window of prefrontal function in children. Dev Neuropsychol 1991; 7:131-149.
9. Zelazo PD, Müller U, Frye D, Marcovitch S. The development of executive function in early childhood. Monographs for the Society for Research in Child Development 2003; 68.
10. Reyna VF, Farley F. Risk and rationality in adolescent decision making: Implications for theory, practice, and public policy. Psychol Sci Public Interest. 2006; 7(1):1-44.
11. DiChiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci 1988; 85:5274-5278.
12. Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, Dewey SL, Wolf AP. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 1993; 14:169-177.
13. Staley JK, Hearn WL, Ruttenber AJ, Wetli CV, Mash DC. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. J Pharmacol Exp Ther 1994, 271:1678-1685.
14. Baxter LR, Schwartz JM, Phelps ME, Mazziota JC, Barrio J, Rawson RA, Engel J, Guze BH, Selin C, Sumida R. Localization of neurochemical effects of cocaine and other stimulants in the human brain. J Clin Psychiat 1988; 49:23-26.
15. Dom G, Sabbe B, Hulstijn W, Van Den Brink W. Substance use disorders and the orbitofrontal cortex: systematic review of behavioural decisionmaking and neuroimaging studies. Brit J Psychiat 2005; 187:209-220.
16. Bechara A, DeMasio H. Decision-making and addiction (part 1): Impaired activation of the somatic states in substance dependent individuals when pondering decisions with negative future consequences. Neuropsychologia 2002; 40:1675-1689.
17. Haber SN, Kunishio K, Mizobuchi M, Lynd-Balta E. The orbital and medial prefrontal circuit through the primate basal ganglia. J Neurosci 1995; 15:4851-4867.
18. Ray JP, Price JL. The organization of projections from the mediodorsal nucleus of the thalamus to orbital and medial prefrontal cortex in macaque monkeys. J Comp Neurol 1993; 337:1-31.
19. Bechara A, Damasio AR, Damasio H. Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994; 50:7-15.
20. Goldstein RZ, Volkow ND. Drug Addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiat 2002; 159:1642-1652.
21. Buckman JF, Bates ME, Morgenstern J. Social support and cognitive impairment in clients receiving treatment for alcohol- and druguse disorders: a replication study. J Stud Alcohol Drugs 2008; 69:738-746.
22. Bierman KL, Nix RL, Greenberg MT, Blair CB, Domitrovich CE. Executive functions and school readiness intervention: Impact, moderation, and mediation in the Head Start REDI program. Dev Psychopathol 2008; 20:821-843.
23. Fishbein DH, Hyde C, Eldreth D, Paschall MJ, Hubal R, Das A, Tarter R, Ialongo N, Hubbard S, Yung B. Neurocognitive skills moderate urban male adolescents' responses to preventive intervention materials. Drug and Alcohol Depend 2006; 82:47-60.
24. Tarter RE. Evaluation and treatment of adolescent substance abuse: A decision tree method. Am J Drug Alcohol Ab 1990; 16:1-46.
25. Greenberg MT, Kusche CA. Promoting Alternative Thinking Strategies. Blueprint for Violence Prevention (Book 10), Institute of Behavioral Sciences, University of Colorado, 1998.
26. Riggs NR, Greenberg MT, Kusch́e CA, Pentz MA. The mediational role of neurocognition in the behavioral outcomes of a social-emotional prevention program in elementary school students: Effects of the PATHS Curriculum. Prev Sci 2006; 7:91-102.
27. Riggs NR, Greenberg MT. The role of neurocognitive models in prevention research. The Science, Treatment, and Prevention of Antisocial Behaviors: Evidence-based practice (Volume II). Fishbein D, ed. Kingston, NJ: Civic Research Institute, Inc., 2004: 8(1-20).
28. Wise RA. Neurobiology of addiction. Curr Opin Neurobiol 1996; 6:243-251.
29. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE.Monitoring the Future national survey results on drug use, 1975-2004.Volume I: Secondary school students NIH Publication No. 05-5727. Bethesda, MD: NIDA, 2005.
30. Dawson DA, Goldstein RB, Chou SP, Ruan WJ, Grant BJ. Age at first drink and the first incidence of adult-onset DSM-IV alcohol use disorders. Alcohol Clin Exp Res 2008; 32:2149-2160.
31. Hawkins JD, Catalano RF, Miller JY. Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: Implications for substance abuse prevention. Psych Bull 1992; 112:64-105.
32. Steinberg L, Dahl R, Keating D, Kupfer DJ, Masten AS, Pine D. The study of developmental psychopathology in adolescence: Integrating affective neuroscience with the study of context. In Handbook of Developmental Psychopathology (2nd ed.).Cicchetti D, CohenD, eds.Hoboken,NJ:Wiley, 2006; 710-741.
33. Keating DP. Cognitive and brain development. In Handbook of Adolescent Psychology (2nd ed.) Lerner RJ, Steinberg LD, eds. New York, NY:Wiley, 2004.
34. Thush C,Wiers RW, Ames SL, Grenard JL, Sussman S, Stacy AW. Interactions between implicit and explicit cognition and workingmemory capacity in the prediction of alcohol use in at-risk adolescents. Drug and Alcohol Dep 2008; 94:116-124.
35. Stacy AW, Ames SL, Knowlton B. Neurologically plausible distinctions in cognition relevant to drug use etiology and prevention. Subst Use Misuse 2004; 39:1571-1623.
36. McNab F, Varrone A, Farde L, Jucaite A, Bystritsky P, Forssberg H. Klingberg T. Changes in cortical dopamine D1 receptor binding associated with cognitive training. Science 2009; 323:800-802.